Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma

Gynecologic Oncology

Volumn 66, Issue 2, 1997, Pages 246-249

  Pierga, J Y ^a   Dieras V ^a   Beuzeboc, P ^a   Dorval, T ^a   Palangie T ^a   Jouve, M ^a   Scholl, S M ^a   Garcia Giralt, E ^a   Pouillart, P ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; ENDOMETRIUM CARCINOMA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MUCOSA INFLAMMATION; NEUROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; SURVIVAL TIME; THROMBOCYTOPENIA;

EID: 0031213548     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4749     Document Type: Article

References (11)

1. Muss H B. Chemotherapy of metastatic endometrial cancer. Semin Oncol. 21:1994;107-113.
2. Moore T D, Phillips P H, Nerenstone S R, Cheson B D. Systemic treatment of advanced and recurrent endometrial carcinoma: Current status and future prospects. J Clin Oncol. 9:1991;1071-1088.
3. Thigpen T, Blessing J, Homesley H. Phase III trial of doxorubicin +/- cisplatin in advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study. Proc Am Soc Clin Oncol. 12:1993;261.
4. Aapro M, Bolis G, Chevallier B. An EORTC-GCCG randomized phase II trial of doxorubicin (DOX) versus DOX-cisplatin (CDDP) in endometrial carcinoma. Proc Am Soc Clin Oncol. 13:1994;275.
5. Pierga J Y, Diéras V, Paraiso D. Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin and 5-fluorouracil: A phase II study. Gynecol Oncol. 60:1996;59-63.
6. Durand R E, Goldie J H. Interaction of etoposide and cisplatin in an in vitro tumor model. Cancer Treat Rep. 71:1987;673-679.
7. Cornelison T L, Baker T R, Piver M S, Driscoli D L. Cisplatin, doxorubicin, etoposide, megestrol acetate (PAV-M) versus melphalan, 5-fluorouracil, medroxyprogesterone acetate (MFP) in the treatment of endometrial carcinoma. Proc Am Soc Clin Oncol. 14:1995;284.
8. O'Connel M J. A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. Cancer. 63:1989;1026-1030.
9. Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
10. Slayton R E, Blessing J A, Delgado G. Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma. Cancer Treat Rep. 66:1982;1669-1671.
11. DeVita V T, Wasserman T H, Young R C, Carter S K. Perspectives on research in gynecologic oncology: Treatment protocols. Cancer. 38:1976;509-525.